Typhonium flagelliforme decreases telomerase expression in HeLa cervical cancer cells

Main Article Content

Endang Purwaningsih
Yulia Suciati
Etty Widayanti


Cancer cells have a relatively high telomerase activity compared to normal cells, so that cancer cells have the ability for continued proliferation and uncontrolled mitosis. Telomerase is an enzyme responsible for the length of telomeres, DNA segments located at the ends of eukaryotic chromosomes. Natural materials such as rodent tuber (Typhonium flagelliforme) have anticancer potential. The purpose of the present study was to determine the effects of Typhonium flagelliforme extract on telomerase expression in HeLa cervical cancer and T47D breast cancer cells.


This experimental laboratory study was conducted on cultured HeLa and T47D cancer cell lines, with normal Vero cells as controls, and using RPMI and M199 culture media. The study comprised three groups, i.e. controls, and groups receiving Typhonium flagelliforme extract at doses of ½ IC50 and IC50. Telomerase expression was measured by immunohistochemistry (IHC). Analysis of variance and LSD multiple comparison test were used to analyze the data.


Telomerase expression in cancer cells showed significantly higher values compared to normal Vero cells. Typhonium flagelliforme extract was capable of significantly decreasing telomerase expression in cancer cells receiving the extract.


Typhonium flagelliforme extract at different doses is capable of decreasing telomerase expression more effectively in cervical cancer cells than in breast cancer cells. This study shows that Typhonium flagelliforme may have anti-cancer activity, necessitating further investigations.

Article Details

How to Cite
Purwaningsih, E., Suciati, Y., & Widayanti, E. (2016). Typhonium flagelliforme decreases telomerase expression in HeLa cervical cancer cells. Universa Medicina, 35(1), 3–9. https://doi.org/10.18051/UnivMed.2016.v35.3-9
Original Articles
Author Biography

Endang Purwaningsih, Department of Anatomy, Faculty of Medicine, YARSI University, Jakarta



Farida Y, Rahayu L, Faizatun. Aktivitas antioksidan Serbuk n-Heksana dan metanol hasil pengeringan semprot ekstrak keladi tikus (Typhonium flagelliforme L) Decne. Kongres Ilmiah XVIII Ikatan Apoteker Indonesia 2010;10 – 12 Desember 2010. Makasar;2010.

Putra A, Tjahjono, Winarto. Ekstrak keladi tikus (Typhonium flagelliforme) fraksi diklorometanolik dan ekspresi caspase-3 dan p21 cell line kanker payudara MCF-7. M Med Indones 2011;45:95-104.

Chadidjah, Nasihun T, Widayati E, Goenarwo E. Typhonium flagelliforme decreases protein expression in murine breast cancer. Univ Med 2014;33:161-170.

Purwaningsih E, Widayanti E, Suciati Y. Cytotoxicity assay of Typhonium flagelliforme Lodd against breast and cervical cancer cells. Univ Med 2014;33:75-82.

Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010;3:9-18.

Hariana HA. Tumbuhan Obat dan khasiatnya. Jakarta: Penerbit Swadaya: 2013.

Mankaran S, Dinesh K, Deepak S, Gurmeet S. Typhonium falgelliforme: a multipurpose plant. Int Res J Pharm 2013;4:45-8.

Mohan S, Abdul AB, Wahab SIA, Al-Zubairi AS. Antibacterial and antioxidant activities of Typhonium flagelliforme (Lodd) Blume tuber. Am J Biochem Biotech 2008;4:402-7.

Mohan S, Abdul AB, Abdelwahab S, et al. Typhonium flagelliforme inhibits the proliferation of murine leukemia WEHI-3 cells in vitro and induced apoptosis in vivo. Leuk Res 2010;34:1483-92.

Syahid, Kristina NN. Induksi dan regenerasi kalus keladi tikus (Typhonium flagelliforme Lood) secara in vitro. Jurnal Littri 2007;13:142-6.

de Virgilio M, Lombardi A, Caliandro R, et al. Ribosom in activating protein: from plant defense to tumor attack. Toxin 2010;2:2699-737.

Kainsa S, Kumar P, Rani P. Medicinal plants of Asian origin having anticancer potential: short review. Asian J Biomed Pharm Sci 2012;2:1-7.

Chadidjah, Dharmana E, Susanto H, et al. Typhonium flagelliforme decreased tyrosine kinase and Ki67 expression in mice. Univ Med 2013;32:46-54.

Lai Cs, Mas RHM, Nair NK, et al. Typhonium flagelliforme inhibits cancer cell growth in vitro and induces apoptosis: an evaluation by the bioactivity guided approach. J Ethnopharmacol 2008;18:14-20.

Lai CS, Mas RH, Nair NK, et al. Chemical constituent and in vitro anticancer activity of Typhonium flagelliforme (Aracaceae). J Ethnopharmacol 2010;127:486-94.

Joseph I, Tressler R, Bassett E, et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res 2010;70:9494-504. DOI: 10.1158/0008-5472.CAN-10-0233.

Sakin V, Eskiocak U, Kars MD, et al. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells. Exp Oncol 2008; 30:202–5.

Quellette MW, Wright WE, Shay JW. Targeting telomerase expressing cancer cells. J Cell Mol Med 2011;15:1433-42.

Masutomi K, Yu FY, Khurts S, et al. Telomerase maintans telomere structure in normal human cells. Cell 2003;114:241-53.

Shay JW, Wright WE. Telomeres and telomerase in normal and cancer stem cells. FEBS Letters 2010;584:3819–25.

Shay JW, Wright WE. Role of telomer and telomerase. Biology 2011;21:349 -53.

Nowak J, Januszzkiewicz, Lewandowski K, et al. Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patient. Eur J Gastroenterol 2003; 15:75–80.

Ivankovic M, Cukusic A, Gotic I. Telomerase activity in HeLa cervical carcinoma cell line proliferation. Biogerontology 2007;8:163-72.

Nasiri M, Zhargami N, Koshki KN, et al. Curcumin silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pasific J Cancer Prev 2013;14:3449–53.

Zisuh AV, Han TQ, Expression of telomerase and its significance in the diagnosis of pancreatic cancer. Indian J Med Res 2012;135:26 -30.